Healthcare
M&A Advisory
Pharmaceutical
Research
Global
M&A Advisory
Lazard
Full Credential Description
UCB Biopharma. United Arab Emirates, Belgium, China, Singapore. Announced Date 26/08/2024. Closed Date 29/11/2024. Deal value: $680m. UCB to Accelerate Innovation and Strategic Partnerships, Divesting Mature Product Portfolio in China. Industry: UCB Biopharma is a global biopharmaceutical company specializing in the research, development, and commercialization of innovative medicines for severe diseases in immunology and neurology.